RecruitingNCT06895798

Differential Impact of Pringle and Portal Vein Occlusion on Myocardial Injury After Non-Cardiac Surgeries.

Differential Impact of Pringle Occlusion vs. Portal Vein Occlusion-Induced Liver Ischaemia-Reperfusion Injury on Myocardial Injury Following Noncardiac Surgeries.


Sponsor

Beijing Tsinghua Chang Gung Hospital

Enrollment

800 participants

Start Date

Jan 4, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate the impact of hepatic ischemia-reperfusion injury (HIRI) on the incidence of myocardial injury after non-cardiac surgery (MINS) and explore the potential underlying mechanisms. A bidirectional cohort study will be conducted, enrolling patients scheduled for major hepato-biliary surgery. Clinical data, perioperative parameters, and postoperative follow-up data will be systematically collected. The incidence of MINS between patients undergoing Pringle occlusion and portal vein occlusion will be compared, and a multivariate analysis will be performed to identify independent risk factors for MINS, providing a basis for early recognition and prevention of MINS.


Eligibility

Min Age: 45 YearsMax Age: 85 Years

Inclusion Criteria4

  • Age ≥ 65 years, or ≥ 45 years with cardiovascular risk factors (especially known cardiovascular disease).
  • Undergoing elective major hepatopancreatobiliary surgery under general anesthesia.
  • ASA physical status II-III.
  • Provide written informed consent to participate in the study (applicable to the prospective cohort).

Exclusion Criteria5

  • Emergency surgery
  • Preoperative diagnosis of myocardial infarction or unstable angina
  • Severe hepatic insufficiency (Child-Pugh class C)
  • Concomitant severe organ dysfunction (e.g., renal failure, respiratory failure)
  • Concomitant active infectious disease

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine,Tsinghua University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06895798


Related Trials